← Leaderboards
Michael Karin
University Of California, San Diego
$60,628,305
Attributed
$71,778,286
Total exposure
42
Grants
32
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$80,877,898 · 43
By mechanism
R01$44,288,368 · 16
U54$9,734,613 · 3
U01$9,546,129 · 3
R37$8,186,868 · 2
P42$5,283,360 · 4
P01$3,235,737 · 5
Top collaborators
- Jane C. Figueiredo8 shared
- Akil Merchant7 shared
- Andrew M Lowy6 shared
- Robert F. Schwabe6 shared
- Anthony Boutros El-Khoueiry5 shared
- Tatiana Kisseleva5 shared
- Jun Hee Lee5 shared
- Jorge Moscat5 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- David A Brenner$18,624,596
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResponseSignal TransductionMediatingInflammationCellsTumorMouse ModelTranscription FactorPathway InteractionsAffectLiverBaseChronicPathogenesisPreventProductionInflammatoryAblationGrowthMalignant Neoplasm Of LiverPrimary Carcinoma Of The Liver CellsPhosphotransferasesCytokine
Grant awards (200)
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$1,152,768
U01 · FY2025 · CA · contact PI
Effects of early life Triclosan exposure through lactation on the gut-liver axis and its implications in the development of steatotic liver disease in adults$794,841
R01 · FY2025 · ES
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy$695,955
R01 · FY2025 · CA · contact PI
Collagen fibers and fragments regulate pancreatic cancer metabolism and growth$532,713
R01 · FY2025 · CA · contact PI
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism$508,692
R01 · FY2025 · DK · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$389,397
R37 · FY2025 · AI · contact PI
Project 1: Control of NASH to HCC progression by the NRF2-FBP1 tug-of-war$350,066
P01 · FY2025 · CA · contact PI
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$340,748
R01 · FY2025 · DK · contact PI
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism$305,120
R01 · FY2025 · DK · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$285,087
R37 · FY2025 · AI · contact PI
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$253,699
R01 · FY2025 · DK · contact PI
Collagen fibers and fragments regulate pancreatic cancer metabolism and growth.$178,265
R01 · FY2025 · CA · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$110,000
U01 · FY2025 · CA · contact PI
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$989,284
U54 · FY2024 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$776,779
U01 · FY2024 · CA · contact PI
Collagen fibers and fragments regulate pancreatic cancer metabolism and growth.$725,478
R01 · FY2024 · CA · contact PI
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism$650,734
R01 · FY2024 · DK · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$600,599
R37 · FY2024 · AI · contact PI
Project 1: Control of NASH to HCC progression by the NRF2-FBP1 tug-of-war$573,624
P01 · FY2024 · CA · contact PI
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy$535,708
R01 · FY2024 · CA · contact PI
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$524,457
R01 · FY2024 · DK · contact PI
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$2,350,878
U54 · FY2023 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$955,015
U01 · FY2023 · CA · contact PI
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism$684,436
R01 · FY2023 · DK · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$600,599
R37 · FY2023 · AI · contact PI
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy$563,902
R01 · FY2023 · CA · contact PI
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$546,309
R01 · FY2023 · DK · contact PI
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors$542,443
R01 · FY2023 · CA · contact PI
The effect of cancer cell produced collagen 1 homotrimers on DDR1 signaling activation by microenvironmental collagen 1 fragments.$174,500
U01 · FY2023 · CA · contact PI
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$1,738,155
U54 · FY2022 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$971,140
U01 · FY2022 · CA · contact PI
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$725,319
U01 · FY2022 · AA · contact PI
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism$705,251
R01 · FY2022 · DK · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$590,745
R37 · FY2022 · AI · contact PI
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors$542,443
R01 · FY2022 · CA · contact PI
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$440,000
U54 · FY2022 · CA
Admin-Core-001$440,000
U54 · FY2022 · CA
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$417,724
R01 · FY2022 · DK · contact PI
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$195,001
U54 · FY2022 · CA
Admin-Core-001$195,001
U54 · FY2022 · CA
Role of p62/SQSTM1 in obesity-induced liver cancer$726,246
R01 · FY2021 · CA · contact PI
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$725,319
U01 · FY2021 · AA · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$590,745
R37 · FY2021 · AI · contact PI
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors$552,492
R01 · FY2021 · CA · contact PI
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$417,063
R01 · FY2021 · DK · contact PI
Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells$332,907
P42 · FY2021 · ES · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$33,788
R37 · FY2021 · AI · contact PI
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$3,386,294
U54 · FY2020 · CA
Role of p62/SQSTM1 in obesity-induced liver cancer$726,246
R01 · FY2020 · CA · contact PI
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$724,384
U01 · FY2020 · AA · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$590,745
R37 · FY2020 · AI · contact PI
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors$551,762
R01 · FY2020 · CA · contact PI
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$416,402
R01 · FY2020 · DK · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$371,655
R37 · FY2020 · AI · contact PI
Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells$298,013
P42 · FY2020 · ES · contact PI
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$724,197
U01 · FY2019 · AA · contact PI
Role of p62/SQSTM1 in obesity-induced liver cancer$704,458
R01 · FY2019 · CA · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$590,745
R37 · FY2019 · AI · contact PI
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors$550,740
R01 · FY2019 · CA · contact PI
Control of Lipogenesis and Hepatic Steatosis by Caspase-2$415,961
R01 · FY2019 · DK · contact PI
Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells$312,375
P42 · FY2019 · ES · contact PI
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$737,531
U01 · FY2018 · AA · contact PI
Role of p62/SQSTM1 in obesity-induced liver cancer$726,246
R01 · FY2018 · CA · contact PI
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$590,745
R37 · FY2018 · AI · contact PI
The Role of IL-17 in Alcoholic Liver Disease and Cancer$353,250
U01 · FY2018 · AA
Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells$347,390
P42 · FY2018 · ES · contact PI
p62, Autophagy, and Cellular Stress in Pancreatitis$242,259
P01 · FY2018 · DK · contact PI
Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells$50,000
P42 · FY2018 · ES · contact PI
Role of p62/SQSTM1 in obesity-induced liver cancer$739,996
R01 · FY2017 · CA · contact PI
Regulation of NF-kappaB and IKK by proinflammatory stimuli$492,288
R01 · FY2017 · AI · contact PI
The Role of IL-17 in Alcoholic Liver Disease and Cancer$353,250
U01 · FY2017 · AA
Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells$299,658
P42 · FY2017 · ES · contact PI
IKK <alpha> and the Control of Prostate Cancer Metastasis$257,099
R01 · FY2017 · CA · contact PI
p62, Autophagy, and Cellular Stress in Pancreatitis$242,259
P01 · FY2017 · DK · contact PI
Regulation of NF-kappaB and IKK by proinflammatory stimuli$492,288
R01 · FY2016 · AI · contact PI
Role of Inflammation in tumor promotion and progression$446,701
R01 · FY2016 · CA · contact PI
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer$382,893
R01 · FY2016 · CA · contact PI
The Role of IL-17 in Alcoholic Liver Disease and Cancer$353,250
U01 · FY2016 · AA
Project 1: Effects of Superfund Toxicants on Liver Cancer Progenitors$290,389
P42 · FY2016 · ES · contact PI
IKK <alpha> and the Control of Prostate Cancer Metastasis$257,099
R01 · FY2016 · CA · contact PI
p62, Autophagy, and Cellular Stress in Pancreatitis$242,259
P01 · FY2016 · DK · contact PI
Regulation of NF-kappaB and IKK by proinflammatory stimuli$492,288
R01 · FY2015 · AI · contact PI
Role of Inflammation in tumor promotion and progression$446,701
R01 · FY2015 · CA · contact PI
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer$382,893
R01 · FY2015 · CA · contact PI
TOR signaling and autophagy in obesity-promoted liver tumorigenesis$351,277
R01 · FY2015 · CA · contact PI
The Role of IL-17 in Alcoholic Liver Disease and Cancer$342,652
U01 · FY2015 · AA
Project 1: Effects of Superfund Toxicants on Liver Cancer Progenitors$299,044
P42 · FY2015 · ES · contact PI
IKK <alpha> and the Control of Prostate Cancer Metastasis$257,099
R01 · FY2015 · CA · contact PI
p62, Autophagy, and Cellular Stress in Pancreatitis$242,259
P01 · FY2015 · DK · contact PI
Regulation of NF-kappaB and IKK by proinflammatory stimuli$492,288
R01 · FY2014 · AI · contact PI
TOR signaling and autophagy in obesity-promoted liver tumorigenesis$469,980
R01 · FY2014 · CA · contact PI
Role of Inflammation in tumor promotion and progression$433,300
R01 · FY2014 · CA · contact PI
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer$371,406
R01 · FY2014 · CA · contact PI
The Role of IL-17 in Alcoholic Liver Disease and Cancer$366,775
U01 · FY2014 · AA
Project 1: Effects of Superfund Toxicants on Liver Cancer Progenitors$282,163
P42 · FY2014 · ES · contact PI
IKK <alpha> and the Control of Prostate Cancer Metastasis$249,386
R01 · FY2014 · CA · contact PI
p62, Autophagy, and Cellular Stress in Pancreatitis$243,585
P01 · FY2014 · DK · contact PI
Regulation of NF-kappaB and IKK by proinflammatory stimuli$462,751
R01 · FY2013 · AI · contact PI
Role of Inflammation in tumor promotion and progression$419,899
R01 · FY2013 · CA · contact PI
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer$359,919
R01 · FY2013 · CA · contact PI
TOR signaling and autophagy in obesity-promoted liver tumorigenesis$331,357
R01 · FY2013 · CA · contact PI
Project 1: Effects of Superfund Toxicants on Liver Cancer Progenitors$308,310
P42 · FY2013 · ES · contact PI
IKK <alpha> and the Control of Prostate Cancer Metastasis$257,099
R01 · FY2013 · CA · contact PI
Effects of Retinoids on the Mucosal Immune System$251,737
P01 · FY2013 · DK · contact PI
Regulation of NF-kapaB and IKK by proinflammatory stimuli$467,908
R01 · FY2012 · AI · contact PI
Role of Inflammation in tumor promotion and progression$446,341
R01 · FY2012 · CA · contact PI
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer$382,893
R01 · FY2012 · CA · contact PI
TOR signaling and autophagy in obesity-promoted liver tumorigenesis$353,140
R01 · FY2012 · CA · contact PI
Pulmonary inflammation and lung cancer development and progression$327,195
R01 · FY2012 · CA · contact PI
Project 1: Effects of Superfund Toxicants on Liver Cancer Progenitors$290,657
P42 · FY2012 · ES · contact PI
Effects of Retinoids on the Mucosal Immune System$258,290
P01 · FY2012 · DK · contact PI
Regulation of NF-kapaB and IKK by proinflammatory stimuli$468,095
R01 · FY2011 · AI · contact PI
Role of inflammation in tumor promotion and progression$445,260
R01 · FY2011 · CA · contact PI
TOR signaling and autophagy in obesity-promoted liver tumorigenesis$352,646
R01 · FY2011 · CA · contact PI
Stress Signaling Pathways in Toxicity and Disease$339,529
R01 · FY2011 · ES · contact PI
Pulmonary inflammation and lung cancer development and progression$327,566
R01 · FY2011 · CA · contact PI
IKK<alpha> and the control of prostate cancer metastasis$256,269
R01 · FY2011 · CA · contact PI
SESTRIN IS A FEEDBACK INHIBITOR OF TOR THAT PREVENTS AGE-RELATED PATHOLOGIES$37,024
P41 · FY2011 · RR · contact PI
Role of inflammation in tumor promotion and progression$459,777
R01 · FY2010 · CA · contact PI
Regulation of NF-kapaB and IKK by proinflammatory stimuli$444,208
R01 · FY2010 · AI · contact PI
Stress Signaling Pathways in Toxicity and Disease$350,384
R01 · FY2010 · ES · contact PI
Pulmonary inflammation and lung cancer development and progression$338,259
R01 · FY2010 · CA · contact PI
IKK<alpha> and the control of prostate cancer metastasis$264,195
R01 · FY2010 · CA · contact PI
Regulation of NF-kapaB and IKK by proinflammatory stimuli$58,194
R01 · FY2010 · AI · contact PI
DEATH RECEPTOR-MEDIATED MITOCHONDRIAL DYSFUNCTION$35,848
P41 · FY2010 · RR · contact PI
Role of inflammation in tumor promotion and progression$32,187
R01 · FY2010 · CA · contact PI
Role of inflammation in tumor promotion and progression$451,497
R01 · FY2009 · CA · contact PI
Regulation of NF-kapaB and IKK by proinflammatory stimuli$436,609
R01 · FY2009 · AI · contact PI
Stress Signaling Pathways in Toxicity and Disease$353,926
R01 · FY2009 · ES · contact PI
Pulmonary inflammation and lung cancer development and progression$332,354
R01 · FY2009 · CA · contact PI
Mouse Strain With Elevated Sensitivity to Chemical$300,716
P42 · FY2009 · ES · contact PI
IKK<alpha> and the control of prostate cancer metastasis$264,195
R01 · FY2009 · CA · contact PI
IKK<alpha> and the control of prostate cancer metastasis$264,045
R01 · FY2009 · CA · contact PI
Role of inflammation in tumor promotion and progression$86,520
R01 · FY2009 · CA · contact PI
DEATH RECEPTOR-MEDIATED MITOCHONDRIAL DYSFUNCTION$46,752
P41 · FY2009 · RR · contact PI
Role of inflammation in tumor promotion and progression$450,258
R01 · FY2008 · CA · contact PI
Regulation of NF-kapaB and IKK by proinflammatory stimuli$424,875
R01 · FY2008 · AI · contact PI
Stress Signaling Pathways in Toxicity and Disease$353,922
R01 · FY2008 · ES · contact PI
How Anthrax lethal factor kills macrophages$353,462
R01 · FY2008 · AI · contact PI
Pulmonary inflammation and lung cancer development and progression$322,905
R01 · FY2008 · CA · contact PI
Mouse Strain With Elevated Sensitivity to Chemical$306,888
P42 · FY2008 · ES · contact PI
IKK<alpha> and the control of prostate cancer metastasis$264,195
R01 · FY2008 · CA · contact PI
Role of inflammation in tumor promotion and progression$53,343
R01 · FY2008 · CA · contact PI
TGFBETA INDUCED IKKALPHA NUCLEAR TRANSLOCATION$976
P41 · FY2008 · RR · contact PI
NUCLEAR FACTOR-KAPPAB IN CANCER DEVELOPMENT AND PROGRESSION$976
P41 · FY2008 · RR · contact PI
Role of inflammation in tumor promotion and progression$413,475
R01 · FY2007 · CA · contact PI
How Anthrax lethal factor kills macrophages$360,308
R01 · FY2007 · AI · contact PI
INTERACTIONS OF HEAVY METAL IONS WITH THE HUMAN GENOME$360,308
R37 · FY2007 · ES · contact PI
Regulation of NF-kB and IKK by proinflammatory stimuli$360,308
R01 · FY2007 · AI · contact PI
Stress Signaling Pathways in Toxicity and Disease$357,439
R01 · FY2007 · ES · contact PI
Mouse Strain With Elevated Sensitivity to Chemical$301,764
P42 · FY2007 · ES · contact PI
IKK<alpha> and the control of prostate cancer metastasis$241,414
R01 · FY2007 · CA · contact PI
Innate Immunity and Host Protection in Mucosal INjury and Infection$217,255
P01 · FY2007 · DK · contact PI
Stress Activated Protein Kinases as Mediators of Disease$437,858
R01 · FY2006 · ES · contact PI
Regulation of NF-kB and IKK by proinflammatory stimuli$371,070
R01 · FY2006 · AI · contact PI
How Anthrax lethal factor kills macrophages$371,070
R01 · FY2006 · AI · contact PI
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$371,070
R37 · FY2006 · ES · contact PI
Mouse Strain With Elevated Sensitivity to Chemical$286,054
P42 · FY2006 · ES · contact PI
Functions and Mechanisms of Radiation Induced Responses$222,642
R01 · FY2006 · CA · contact PI
IKKALPHA IN KERATINOCYTE DIFFERENTIATION$6,095
P41 · FY2006 · RR · contact PI
How Anthrax lethal factor kills macrophages$380,000
R01 · FY2005 · AI
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$380,000
R37 · FY2005 · ES
Stress Activated Protein Kinases as Mediators of Disease$380,000
R01 · FY2005 · ES
Regulation of NF-kB and IKK by proinflammatory stimuli$380,000
R01 · FY2005 · AI
Mouse Strain With Elevated Sensitivity to Chemical$276,976
P42 · FY2005 · ES
Functions and Mechanisms of Radiation Induced Responses$228,000
R01 · FY2005 · CA
Stress Activated Protein Kinases as Mediators of Disease$56,128
R01 · FY2005 · ES
IKKALPHA IN KERATINOCYTE DIFFERENTIATION$6,482
P41 · FY2005 · RR
Regulation of NF-kB and IKK by proinflammatory stimuli$380,000
R01 · FY2004 · AI
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$380,000
R37 · FY2004 · ES
Stress Activated Protein Kinases as Mediators of Disease$380,000
R01 · FY2004 · ES
How Anthrax lethal factor kills macrophages$374,800
R01 · FY2004 · AI
Functions and Mechanisms of Radiation Induced Responses$228,000
R01 · FY2004 · CA
IKKALPHA IN KERATINOCYTE DIFFERENTIATION$12,870
P41 · FY2004 · RR
Stress Activated Protein Kinases as Mediators of Disease$380,000
R01 · FY2003 · ES
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$369,600
R37 · FY2003 · ES
How Anthrax lethal factor kills activated macrophages$228,000
R21 · FY2003 · AI
Functions and Mechanisms of Radiation Induced Responses$228,000
R01 · FY2003 · CA
Regulation of NF-kB and IKK by proinflammatory stimuli$190,000
R01 · FY2003 · AI
Stress Activated Protein Kinases as Mediators of Disease$380,000
R01 · FY2002 · ES
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$349,321
R37 · FY2002 · ES
REGULATION OF NFKB AND IKK BY PROINFLAMMATORY STIMULI$324,308
R01 · FY2002 · AI
Functions and Mechanisms of Radiation Induced Responses$228,000
R01 · FY2002 · CA
How Anthrax lethal factor kills activated macrophages$222,800
R21 · FY2002 · AI
Environmental pollutants &oxidative stress$175,014
P42 · FY2002 · ES
Environmental pollutants &oxidative stress$175,014
P42 · FY2002 · ES
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$339,146
R37 · FY2001 · ES
REGULATION OF NFKB AND IKK BY PROINFLAMMATORY STIMULI$314,865
R01 · FY2001 · AI
AP-1 AS A XENOBIOTIC RECEPTOR$264,920
R01 · FY2001 · ES
Environmental pollutants &oxidative stress$175,014
P42 · FY2001 · ES
ROLE OF PROTEIN KINASES AND UV INDUCED STRESS RESPONSE$170,377
R01 · FY2001 · CA
STRESS ACTIVATED PROTEIN KINASES IN GENETIC HYPERTENSION$117,022
P01 · FY2001 · HL
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$329,267
R37 · FY2000 · ES
REGULATION OF NFKB AND IKK BY PROINFLAMMATORY STIMULI$305,695
R01 · FY2000 · AI
AP-1 AS A XENOBIOTIC RECEPTOR$257,205
R01 · FY2000 · ES
STRESS ACTIVATED PROTEIN KINASES IN GENETIC HYPERTENSION$255,122
P01 · FY2000 · HL
Environmental pollutants &oxidative stress$175,014
P42 · FY2000 · ES
ROLE OF PROTEIN KINASES AND UV INDUCED STRESS RESPONSE$113,793
R01 · FY2000 · CA
INTERACTION OF HEAVY METAL IONS WITH THE HUMAN GENOME$73,306
R37 · FY2000 · ES
NF KAPPA B REGULATION AND FUNCTION$5,000
R13 · FY2000 · CA